Broad screening coverage from automatically updated sources
Kyboa combines global sanctions and PEP screening, news search, web search and KYB-focused company information to support practical AML, KYC, KYB and customer due diligence workflows.
The goal is not to overwhelm your team with raw data. The goal is to help you screen the right names, review the right signals and keep a defensible record of what was checked at the time.
Kyboa currently screens against a consolidated sanctions dataset covering 85 global sanctions lists, a broader global screening dataset covering 332 data sources and lists, recent news discovery, broader web discovery, and company information where available and relevant.
Sanctions coverage and key figures
Consolidated Sanctions
85 global sanctions lists
Approximately 98,582 entities
Automatically updated, with timing varying by source.
Broader Global Screening Dataset
332 data sources and lists
Approximately 2,166,965 entities
Automatically updated, with timing varying by source.
The consolidated sanctions dataset includes major international lists as well as regional and country-level lists relevant to Southeast Asia and cross-border business.
Regional examples
Malaysia MOHA Sanctions List, Singapore Targeted Financial Sanctions, Thailand Designated Persons List, Philippines Anti-Money Laundering Council Sanctions, Japan sanctions sources and Australian sanctions sources.
Global examples
UN Security Council Consolidated Sanctions, US OFAC lists, US Trade Consolidated Screening List, UK FCDO Sanctions List, EU sanctions files and Canadian sanctions sources.
Figures are based on the internal source list export dated 6 May 2026. Public website copy should treat these as approximate and subject to change.
PEP, enforcement, watchlist, news and web discovery
PEPs and public roles
Politically exposed persons, relatives and close associates where available, public officials and senior public roles.
Enforcement and watchlists
Regulatory enforcement actions, wanted lists, debarment, exclusions, financial crime sources and other watchlist-style sources where available.
News discovery
Structured news discovery can surface recent public reporting, adverse media signals and regulator or enforcement references for manual review.
Web discovery
Broader web discovery can surface corporate websites, professional profiles, company references, regulator pages and other public context.
Search results are signals for review, not findings. News and web results can include false positives, similar names can refer to different people or companies, and absence of results does not prove absence of risk.
Company information used in KYB workflows
For company screening, Kyboa can use business registration information to strengthen KYB, screening and ongoing CDD workflows where supported.
The value is not simply looking up a company record. The value is using company information to build a better screening file, identify relevant names to screen, and maintain a clearer compliance record over time.
Depending on jurisdiction and available data, Kyboa can help your team confirm company names and local-language names, identify directors or related people, identify shareholders where available, compare information against client-provided data, and keep a maintained record for future re-screening and monitoring.
Malaysia
Enhanced company screening with director and shareholder information where available, supporting ownership review and potential UBO identification.
Thailand and Cambodia
Company screening with business registration context and director information where available, helping screen relevant associated people as part of the KYB process.
and more..
Singapore and other jurisdictions
Enhanced Singapore support is planned. Where structured company information is not yet supported, users can manually maintain company, officer, shareholder and UBO details.
Source updates, auditability and limitations
Source freshness
Screening datasets are updated automatically, with cadence depending on the underlying source list. Some lists refresh every few hours, while others refresh daily, weekly or according to the source’s own schedule.
Point-in-time records
Kyboa reports and audit records show the screening result based on the data available and checks performed at that time.
Clear limitations
No screening platform can prove there is no risk. Results require review, source coverage varies, and company information does not replace official registry documents where those are required.
Kyboa is designed to support a documented, repeatable and reviewable compliance workflow. It helps teams find signals, structure the review and keep evidence of the checks performed.
Frequently Asked Questions
Common questions about sanctions lists, PEP data, watchlists, adverse media, web search, company information and source limitations.
How often are screening lists updated? Show answer Hide answer
Update timing depends on the underlying source. Some lists are refreshed every few hours, while others are refreshed daily, weekly or according to the source’s own schedule.
Does a no-match result mean the customer is safe? Show answer Hide answer
No. A no-match result means the configured screening checks did not return a relevant match at the time of screening. It does not prove absence of risk.
Are news and web results considered evidence? Show answer Hide answer
News and web discovery results are review signals. They may help identify articles, public references or background context, but they should be reviewed carefully before any conclusion is drawn.
Is Kyboa a company registry data provider? Show answer Hide answer
No. Kyboa is a KYB, KYC, AML screening and CDD workflow platform. Company information is used to enhance screening and due diligence workflows where available, not to replace official company registry searches or official registry documents.
What company information can Kyboa use for KYB checks? Show answer Hide answer
Where supported, Kyboa can use company identity, local-language names, registration status, directors, officers, shareholders or beneficial ownership information to support screening and CDD workflows. Data availability and depth vary by jurisdiction.
